EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients

Xiaoqin Le iD, Xueqin Qian, Li Liu, Jianjun Sun, Wei Song, Tangkai Qi, Zhenyan Wang, Yang Tang, Shuibao Xu, Junyang Yang, Jiangrong Wang, Jun Chen und 3 weitere

Viruses · 2024

DOI: 10.3390/v16040627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Xiaoqin Le und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, HIV Infections, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Commission Medical Innovation Research Special Major Project, Shanghai Science and Technology Commission Shanghai infectious diseases (AIDS) Clinical Medical Research Center Project, Shenkang Hospital Development Center Clinical Science and Technology Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trends in and risk factors for drug resistance in Mycobacterium tuberculosis (M. tuberculosis) in human immunodeficiency virus (HIV)-infected patients with active tuberculosis were analyzed. The clinical data of M. tuberculosis and HIV-coinfected patients treated at the Shanghai Public Health Clinical Center between 2010 and 2022 were collected. The diagnosis of tuberculosis was confirmed by solid or liquid culture. The phenotypic drug susceptibility test was carried out via the proportional method, and the resistance to first-line and second-line drugs was analyzed. Logistic regression analysis was performed to identify associated risk factors for drug resistance in M. tuberculosis. Of the 304 patients with a M. tuberculosis-positive culture and first-line drug susceptibility test results, 114 (37.5%) were resistant to at least one first-line anti-tuberculosis drug. Of the 93 patients with first-line and second-line drug susceptibility test results, 40 (43%) were resistant to at least one anti-tuberculosis drug, and 20 (21.5%), 27 (29.0%), 19 (20.4%), 16 (17.2%), and 14 (15.1%) were resistant to rifampicin, streptomycin, ofloxacin, levofloxacin, and moxifloxacin, respectively; 17 patients (18.3%) had multidrug-resistant tuberculosis (MDR-TB). Between 2010 and 2021, the rate of resistance to streptomycin and rifampicin ranged from 14.3% to 40.0% and from 8.0% to 26.3%, respectively, showing an increasing trend year by year. From 2016 to 2021, the rate of resistance to quinolones fluctuated between 7.7% and 27.8%, exhibiting an overall upward trend. Logistic regression analysis showed that being aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisHIV InfectionsAntitubercular AgentsTuberculosis, Multidrug-ResistantMicrobial Sensitivity TestsHumansRisk FactorsFemaleMaleAdultMiddle AgedChinaCoinfectionDrug Resistance, Multiple, BacterialYoung AdultDrug Resistance, BacterialAged

Stichwörter der Autor:innen

HIVMycobacterium tuberculosisquinolonerifampicin

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
  • Department of Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.

ORCID-Profile: Xiaoqin Le, Yinzhong Shen

Förderung

  • Shanghai Science and Technology Commission Medical Innovation Research Special Major Project
  • Shanghai Science and Technology Commission Shanghai infectious diseases (AIDS) Clinical Medical Research Center Project
  • Shenkang Hospital Development Center Clinical Science and Technology Innovation Project
  • Shanghai Municipal Science and Technology Critical Special Project "Research on Key Technologies for Prevention and Control of Major Sudden Infectious Diseases"
  • Shenkang Hospital Development Center Clinical Research Basic Support Project
  • Shanghai Municipal Science and Technology Critical Special Project

Zitieren

APA

Le, X., Qian, X., Liu, L., Sun, J., Song, W., Qi, T., Wang, Z., Tang, Y., Xu, S., Yang, J., Wang, J., Chen, J., Zhang, R., Zhu, Z., & Shen, Y. (2024). Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients. Viruses. https://doi.org/10.3390/v16040627

Vancouver

Le X, Qian X, Liu L, Sun J, Song W, Qi T, et al. Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients. Viruses. 2024. doi:10.3390/v16040627

BibTeX
@article{Le2024,
  author = {Le, Xiaoqin and Qian, Xueqin and Liu, Li and Sun, Jianjun and Song, Wei and Qi, Tangkai and Wang, Zhenyan and Tang, Yang and Xu, Shuibao and Yang, Junyang and Wang, Jiangrong and Chen, Jun and Zhang, Renfang and Zhu, Zhaoqin and Shen, Yinzhong},
  title = {Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16040627}
}
Kostenlos starten →